HIV Mutation Detail Information

> M184V Search Result


Mutation Information
Mutation Site M184V
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Relevant Drug NRTIs
Country Uganda
Literature Information
PubMed PMID 31266818
Disease HIV infection/AIDS
Published Year 2019
Journal Sexually transmitted infections
Title Sustained virological response and drug resistance among female sex workers living with HIV on antiretroviral therapy in Kampala, Uganda: a cross-sectional study.
Author Namale G,Kamacooko O,Bagiire D,Mayanja Y,Abaasa A,Kilembe W,Price M,Ssemwanga D,Lunkuse S,Nanyonjo M,Ssenyonga W,Mayaud P,Newton R,Kaleebu P,Seeley J
Evidence HIV resistance testing was available for 78% (28/38), of whom 82.1% (23/28) had at least one major drug resistance mutation (DRM), most frequently M184V (70%, 16/23) and K103N (65%, 15/23). t one major drug resistance mutation (DRM), most frequently M184V (70%, 16/23) and K103N (65%, 15/23).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation